INmuneBIO Company
INmune Bio, Inc. is developing therapies that harness the patients immune system to treat cancer.
%20.jpg)
Founded Date:
2015
Total Funding:
$48.2M
Employee Number:
11-50
Funding Status:
IPO
Technology:
Data-driven Technologies
Last Funding Type:
Post-IPO Equity
Investors Number:
2
Industry:
PharmTech
Headquarters:
La Jolla, California, United States
Estimated Revenue:
Less than $1M